Research raises concerns over use of chromium diet pills
Australian researchers using synchrotron science have found supplements containing chromium are partially converted into a carcinogenic form when they enter human cells.
Immune system ‘friendly fire’ can turn malaria deadly
New imaging approach to understand cerebral malaria could shed light on neurodegenerative diseases including Parkinson’s and Alzheimer’s.
ACRF funding brings ‘broadband’ protein analysis to Australia
The Australian Cancer Research Foundation (ACRF) has awarded $2m in funding for a new detector at the Australian Synchrotron to help accelerate cancer drug development.
Synchrotron light to shine brighter over next decade
A $520 million, ten-year investment in operations will allow the Australian Synchrotron to further empower researchers and industry to problem solve and innovate.